These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 179316)

  • 21. [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
    Poser W; Ehrenreich H
    Internist (Berl); 1996 Oct; 37(10):1061-7; discussion 1067. PubMed ID: 9019453
    [No Abstract]   [Full Text] [Related]  

  • 22. Narcotic antagonists in opiate dependence.
    Fink M
    Science; 1970 Sep; 169(3949):1005-6. PubMed ID: 4914724
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of cyclazocine in treating narcotic addicts in a low-intervention setting.
    Kleber H; Kinsella JK; Riordan C; Greaves S; Sweeney D
    Arch Gen Psychiatry; 1974 Jan; 30(1):37-42. PubMed ID: 4808735
    [No Abstract]   [Full Text] [Related]  

  • 24. [Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence].
    Heilig M
    Lakartidningen; 2002 Jan; 99(3):200-4. PubMed ID: 11838078
    [No Abstract]   [Full Text] [Related]  

  • 25. Antagonist study in St. Louis.
    Parwatikar S; Crawford J; Unverdi C
    Am J Drug Alcohol Abuse; 1975; 2(3-4):379-90. PubMed ID: 1227299
    [No Abstract]   [Full Text] [Related]  

  • 26. Narcotic antagonists: a reasonable method of treating narcotic dependency.
    Schooff KG; Hersch RG; Keegan JF
    Int J Addict; 1975; 10(3):391-400. PubMed ID: 170227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclazocine treatment of opiate dependence: a progress report.
    Resnick RB; Fink M; Freedman AM
    Compr Psychiatry; 1971 Nov; 12(6):491-502. PubMed ID: 5117068
    [No Abstract]   [Full Text] [Related]  

  • 28. [Detoxification in withdrawal state in methadone maintenance patients].
    Sivolap I; Savchenkov VA; Aksel'rod BA; Kubarev DA; Chichenkov TO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):33-7. PubMed ID: 14681963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of information in naltrexone study.
    Rastegar DA
    Arch Gen Psychiatry; 2007 Jul; 64(7):865; author reply 865. PubMed ID: 17606820
    [No Abstract]   [Full Text] [Related]  

  • 30. The treatment of heroin addiction: naltrexone alone and with behavior therapy.
    Callahan EJ; Rawson RA; McCleave B; Arias R; Glazer M; Liberman RP
    Int J Addict; 1980 Aug; 15(6):795-807. PubMed ID: 7461877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Operant analysis of human heroin self-administration and the effects of naltrexone.
    Mello NK; Mendelson JH; Kuehnle JC; Sellers MS
    J Pharmacol Exp Ther; 1981 Jan; 216(1):45-54. PubMed ID: 7452507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user.
    Hulse GK; O'Neil G; Arnold-Reed DE
    Int J Gynaecol Obstet; 2004 May; 85(2):170-1. PubMed ID: 15099783
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical experiences with narcotic antagonists: cyclazocine and naloxone.
    Proc Natl Conf Methadone Treat; 1973; 1():447-51. PubMed ID: 4808183
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclazocine and methadone in narcotic addiction.
    Freedman AM; Fink M; Sharoff R; Zaks A
    JAMA; 1967 Oct; 202(3):191-4. PubMed ID: 6072354
    [No Abstract]   [Full Text] [Related]  

  • 35. The clinical usefulness of narcotic antagonists: preliminary findings on the use of naltrexone.
    Lewis DC
    Am J Drug Alcohol Abuse; 1975; 2(3-4):403-15. PubMed ID: 1227300
    [No Abstract]   [Full Text] [Related]  

  • 36. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
    Stimmel B
    J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922
    [No Abstract]   [Full Text] [Related]  

  • 37. A history of the development of narcotic antagonists for the treatment of narcotic addiction.
    Martin WR
    NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106
    [No Abstract]   [Full Text] [Related]  

  • 38. Naltrexone implants as treatment for heroin dependence: part I.
    Byrne A; Graham G; Hallinan R; Murnion B
    Addict Biol; 2005 Jun; 10(2):201; author reply 201-2. PubMed ID: 16191674
    [No Abstract]   [Full Text] [Related]  

  • 39. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.
    Kakko J; Grönbladh L; Svanborg KD; von Wachenfeldt J; Rück C; Rawlings B; Nilsson LH; Heilig M
    Am J Psychiatry; 2007 May; 164(5):797-803. PubMed ID: 17475739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Opiate withdrawal in anesthesia (forced narcotic withdrawal, "turbo withdrawal") in narcotic dependence. Changes in withdrawal treatment--wishes and reality].
    Dettling M; Tretter F
    Nervenarzt; 1996 Sep; 67(9):805-10. PubMed ID: 8992381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.